ApicHope Pharmaceutical Co., Ltd
SZSE:300723.SZ
26.51 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 422.522 | 645.596 | 1,075.025 | 726.032 | 710.205 | 751.604 | 85.038 | 94.245 | 29.779 | 37.397 | 28.793 |
| Short Term Investments
| 40.44 | 72.189 | 15.027 | 13 | 35.6 | 25 | 670 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 462.962 | 717.785 | 1,090.052 | 739.032 | 745.805 | 751.604 | 85.038 | 94.245 | 29.779 | 37.397 | 28.793 |
| Net Receivables
| 492.831 | 483.691 | 299.732 | 315.689 | 323.24 | 361.526 | 245.853 | 207.892 | 138.4 | 269.479 | 76.431 |
| Inventory
| 346.435 | 178.025 | 114.971 | 110.059 | 81.649 | 78.111 | 133.619 | 99.571 | 109.005 | 75.726 | 48.593 |
| Other Current Assets
| 57.634 | 31.828 | 58.845 | 44.249 | 27.348 | 27.116 | 674.95 | 3.697 | 0.87 | 4.404 | 0.002 |
| Total Current Assets
| 1,359.862 | 1,411.328 | 1,563.6 | 1,209.03 | 1,178.042 | 1,218.356 | 1,139.46 | 405.405 | 278.054 | 387.006 | 153.819 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 1,798.581 | 1,686.486 | 1,042.989 | 504.3 | 266.915 | 197.55 | 176.043 | 166.263 | 177.853 | 183.701 | 153.402 |
| Goodwill
| 11.282 | 11.282 | 11.282 | 0.256 | 0.256 | 0.256 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 446.794 | 460.966 | 460.419 | 298.341 | 312.91 | 349.333 | 159.692 | 171.906 | 165.226 | 155.009 | 90.995 |
| Goodwill and Intangible Assets
| 458.077 | 472.249 | 471.701 | 298.597 | 313.166 | 349.589 | 159.692 | 171.906 | 165.226 | 155.009 | 90.995 |
| Long Term Investments
| 593.11 | 312.249 | 392.984 | 25 | 0.198 | 0 | 0 | 0 | 0.255 | 0.474 | 0.693 |
| Tax Assets
| 54.34 | 47.325 | 12.998 | 9.192 | 13.093 | 7.474 | 4.382 | 1.959 | 2.004 | 1.187 | 3.228 |
| Other Non-Current Assets
| 141.326 | 168.806 | 220.142 | 99.039 | 23.392 | 7.976 | 2.304 | 6.785 | 7.167 | 6.427 | 9.131 |
| Total Non-Current Assets
| 3,045.433 | 2,687.114 | 2,140.815 | 936.128 | 616.764 | 562.59 | 342.421 | 346.913 | 352.504 | 346.798 | 257.449 |
| Total Assets
| 4,405.296 | 4,098.442 | 3,704.415 | 2,145.158 | 1,794.806 | 1,780.946 | 1,481.881 | 752.318 | 630.558 | 733.804 | 411.268 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 202.4 | 84.829 | 40.653 | 56.07 | 20.444 | 19.449 | 13.269 | 17.545 | 16.812 | 59.176 | 86.532 |
| Short Term Debt
| 616.393 | 577.717 | 876.282 | 290.039 | 197.598 | 279.34 | 1.807 | 27.866 | 60 | 96.433 | 79.55 |
| Tax Payables
| 112.95 | 65.445 | 41.813 | 22.574 | 36.908 | 36.736 | 20.637 | 21.04 | 19.268 | 10.939 | 8.277 |
| Deferred Revenue
| 663.912 | 532.093 | 286.177 | 205.089 | 116.245 | 103.844 | 37.282 | 50.623 | 36.016 | 123.933 | 42.509 |
| Other Current Liabilities
| 6.289 | 14.217 | 2.585 | 5.607 | 50.044 | 20.288 | 51.49 | 26.644 | 17.352 | 26.737 | 16.118 |
| Total Current Liabilities
| 1,488.994 | 1,208.856 | 1,205.698 | 556.805 | 384.331 | 422.921 | 103.847 | 122.679 | 130.18 | 306.28 | 224.708 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 186.034 | 589.941 | 352.78 | 95.247 | 0 | 0 | 250.88 | 290.84 | 295.92 | 300 | 0 |
| Deferred Revenue Non-Current
| 83.341 | 75.755 | 84.445 | 93.335 | 69.867 | 58.745 | 18.722 | 2.3 | 3.8 | 0 | 0.955 |
| Deferred Tax Liabilities Non-Current
| 49.006 | 58.09 | 43.108 | 0 | 0 | 0 | -250.88 | -290.84 | -295.92 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | -95.247 | 0 | 0 | 250.88 | 290.84 | 295.92 | 0 | 0 |
| Total Non-Current Liabilities
| 318.38 | 723.786 | 480.334 | 93.335 | 69.867 | 58.745 | 269.602 | 293.14 | 299.72 | 300 | 0.955 |
| Total Liabilities
| 1,807.374 | 1,932.642 | 1,686.032 | 650.14 | 454.199 | 481.667 | 373.449 | 415.819 | 429.9 | 606.28 | 225.663 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 90.823 | 73.037 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 454.143 | 288.082 | 288.034 | 160.895 | 161.143 | 161.471 | 160 | 120 | 120 | 90 | 90 |
| Retained Earnings
| 1,361.799 | 1,253.029 | 1,044.594 | 776.957 | 589.946 | 480.274 | 300.525 | 154.39 | 20.611 | 7.512 | 61.546 |
| Accumulated Other Comprehensive Income/Loss
| -0 | 36.439 | -90.823 | -73.037 | 63.923 | 28.415 | 49.582 | 58.837 | 55.266 | 0 | -0 |
| Other Total Stockholders Equity
| 706.145 | 473.661 | 541.684 | 547.06 | 513.895 | 628.262 | 596.929 | 0 | 0 | 30.012 | 25.668 |
| Total Shareholders Equity
| 2,522.087 | 2,051.21 | 1,874.312 | 1,484.912 | 1,328.907 | 1,298.422 | 1,107.036 | 333.227 | 195.878 | 127.524 | 177.214 |
| Total Equity
| 2,597.922 | 2,165.801 | 2,018.383 | 1,495.018 | 1,340.607 | 1,299.279 | 1,108.432 | 336.5 | 200.658 | 127.524 | 185.605 |
| Total Liabilities & Shareholders Equity
| 4,405.296 | 4,098.442 | 3,704.415 | 2,145.158 | 1,794.806 | 1,780.946 | 1,481.881 | 752.318 | 630.558 | 733.804 | 411.268 |